SOD1 and amyotrophic lateral sclerosis: On the one hand, these results are surprising, since use of the SOD1-G93A model has been critiqued as mechanistically representing only a minority of ALS patients, most of whom develop sporadic disease, with only 12% of familial cases having a causal SOD1 mutation (Renton et al., 2014).